Our community narratives are driven by numbers and valuation.
Firstly, this is purely to remove the stock from mine and everybody else's radar as Simply is showing this as an undervalued company which is essentially dead in the water and not currently tradeable on the exchange. The following is AI, not my own words, which has a far more explanatory way of putting this.Read more
Ex-pack Corrugated Cartons PLC Introduction Ex-pack Corrugated Cartons PLC, a subsidiary of Aberdeen Group was established in 1997, It is a Manufacturer and marketer of high quality printed corrugated cartons to an infinite range of customized high quality packaging solutions for both sri lankan and export markets. Ex-pack corrugated cartons limited provides conception, design, prototyping and production of die cut, laminated, telescopic and value-added cartons to suite the bespoke packaging requirements of clients.Read more
Cybin’s aggressive analyst price targets make sense when you view the company through a true late-stage biotech lens rather than a speculative psychedelic stock. With more than US$225 million in cash after retiring all debt, Cybin is now one of the only fully funded companies in the entire sector with enough runway to complete multiple Phase 3 trials and deliver two major clinical readouts—Phase 2 CYB004 data in Q1 2026 and pivotal Phase 3 CYB003 results in Q4 2026.Read more
Based on Auxly’s latest financials — now doing roughly $40M/quarter in revenue , running mid-50s gross margins and having turned the corner to consistent, positive EBITDA and net income , a bullish-but-reasonable 12-month price target for XLY lands around $0.30–$0.35. That range assumes Auxly can (1) hold or slightly grow revenue into the $165–$175M annual run-rate, (2) keep EBITDA margins in the high-20s/low-30s, and (3) be rewarded with a modestly re-rated multiple as one of the few profitable, scaled Canadian LPs. At today’s ~$0.155–0.17, that implies roughly a 2x move over the next year — not a moonshot, but a sensible rerating as the market digests that Q3 wasn’t a one-off, balance-sheet risk continues to fall, and more institutions/ETFs are finally willing to touch a profitable, cash-flowing Auxly.Read more
Recent development -USA tariff effect Analysis for brown and company and browns investments (browns and co. holds a little over 63% of browns investments) Browns investments plc acquired 100% ownership of Lipton Teas and Infusions Rwanda Limited and Tanzania Limited, along with 98.56% of Lipton Teas and Infusions Kenya Plc and 51.99% of Limura Tea Plc making it the largest tea producer in the world.Read more
Catalysts Current Defence spend in EU & Globally is surging. Exosens state of the art tech & customer acceptance is impacting positively sales, margins & profits.Read more
AppLovin (NASDAQ: APP) posted another stunning quarter, solidifying its position as one of the most profitable AI-powered software platforms in the public markets. For Q3 2025, revenue surged 68% year-over-year to $1.405 billion , while net income nearly doubled to $836 million , up 92%.Read more
The trading narrative for dLocal (DLO), based on the DCF Valuation - HatedMoats article, is that the stock is significantly undervalued. Key Trading Narrative Points: Verdict: Undervalued.Read more

Catalyst UiPath is built fully around AI, and it sits right between the first and second stages of the AI boom. The first stage focused on building the hardware that makes AI possible.Read more
